达比加群酰基Β维葡糖苷酸 基本信息
| 中文名称 | 达比加群酰基Β维葡糖苷酸 |
|---|---|
| 中文同义词 | N-[[2-[[[4-(氨基亚胺甲基)苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-2-吡啶基-BETA-丙氨酸 BETA-D-吡喃葡糖酸基酯;达比加群酰基Β维葡糖苷酸;达比加群酰基-D-葡萄糖醛酸;达比加群代谢物;达比加群酰基-?-D-葡糖苷酸-D3 TFA盐;达比加群酯酰基-?-D-葡糖苷酸三氟乙酸盐;达比加群酰基-?-D-葡糖苷酸TFA盐;达比加群酰基--?-D-葡萄糖醛酸 三氟乙酸盐 |
| 英文名称 | Dabigatran Acyl-β-D-Glucuronide |
| 英文同义词 | Dabigatran Acyl-β-D-Glucuronide;N-[[2-[[[4-(AMinoiMinoMethyl)phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine β-D-Glucopyranuronosyl Ester;Dabigatran Acyl-Beta-D-Glucuronide;N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine beta-D-glucopyranuronosyl ester;Dabigatran Acyl-β-D-Glucuronide Trifluoroacetic Acid Salt;Dabigatran Acyl-β-D-Glucuronide Trifluoroacetic Acid Salt (80%);Dabigatran Acyl Glucuronide;Dabigatran Acyl-?-D-Glucuronide-D3 TFA Salt |
| CAS号 | 1015167-40-4 |
| 分子式 | C31H33N7O9 |
| 分子量 | 647.64 |
| EINECS号 | |
| 相关类别 | Aromatics;Bases & Related Reagents;Heterocycles;Intermediates & Fine Chemicals;Metabolites & Impurities;Nucleotides;Pharmaceuticals |
| Mol文件 | 1015167-40-4.mol |
| 结构式 |  |
达比加群酰基Β维葡糖苷酸 性质
| 熔点 | >155°C (dec.) |
|---|---|
| 沸点 | 968.1±75.0 °C(Predicted) |
| 密度 | 1.57±0.1 g/cm3(Predicted) |
| 储存条件 | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
| 溶解度 | 可溶于DMSO（微溶）、甲醇（微溶、加热）、水 |
| 形态 | 固体 |
| 酸度系数(pKa) | 2.68±0.70(Predicted) |
| 颜色 | 灰白色至浅棕色 |
| 稳定性 | 吸湿性，溶液不稳定 |
用途
The major metabolite of Dabigatran (D100090) in humans. Four isomeric acylglucuronides of Dabigatran were isolated and purified from urine of dosed rhesus monkeys. NMR analysis confirmed the structur es of the four metabolites as the 1-O-acylglucuronide (β anomer) and the 2-O-, 3-O-, and 4-O-acylglucuronides (α and β anomers).